Prostate Artery Embolization
- Prostate artery embolization (PAE) treats the urinary misery of benign prostatic hyperplasia by deliberately starving the overgrown gland of its blood supply, so it shrinks and softens.
- It's a minimally invasive, catheter-based alternative to surgery (TURP) — no cutting, usually done with the patient awake and home the same day.
- The whole game is anatomy: the prostatic arteries are tiny, tortuous, and wildly variable, so a good cone-beam CT and a careful angiogram are everything.
- The signature risk is non-target embolization — beads landing in the bladder, rectum, or penis instead of the prostate. That's the thing you spend the entire case trying not to do.
- It tends to improve symptoms without the classic surgical trade-offs (it largely spares ejaculatory and erectile function), which is a big part of its appeal.
Imagine a doughnut slowly inflating around a drinking straw. The straw is the urethra; the doughnut is an aging prostate. As the gland swells, it pinches the straw, and the man attached to it spends his nights making increasingly bitter trips to the bathroom. Surgery (the classic TURP — transurethral resection of the prostate) deals with this by reaming out the middle of the doughnut. PAE takes a sneakier route: instead of carving the gland, we cut off its catering.
The big idea: starve it, don't cut it
Every tissue needs blood. The plan in prostate artery embolization (PAE) is to slide a catheter into the small arteries feeding the prostate and inject microscopic beads — microspheres, usually a few hundred micrometers across — until those vessels clog. Deprived of supply, the overgrown tissue undergoes a controlled shrinkage and softening. The doughnut deflates a little, the straw opens back up, and (the hope is) the 3 a.m. bathroom pilgrimages get shorter.
It's a cousin of uterine fibroid embolization — same philosophy of shrinking a benign, hormonally-driven blob by choking its blood supply, just in a different (and considerably more cramped) neighborhood.
PAE doesn't instantly carve out a channel the way TURP does, so relief builds over weeks as the gland involutes — not the same night. Worth saying out loud to the patient before they go home wondering why they still have to pee.
Who it's for
The typical candidate is a man with bothersome lower urinary tract symptoms from BPH — weak stream, urgency, that "I just went, why am I back here" feeling — who has failed or doesn't want medications, and who would rather not have surgery. It's also attractive for men whose glands are very large or who are poor surgical candidates.
Before anyone touches a catheter, the prostate gets imaged — typically by multiparametric prostate MRI or ultrasound — and prostate cancer is worked up and excluded as appropriate, because PAE is a treatment for benign enlargement, not a stand-in for cancer therapy.
The technique: a road trip down very small streets
Access is the same starting move as most of vascular IR: a needle into the common femoral or radial artery, a sheath, then catheters and tiny microcatheters threaded down toward the internal iliac arteries and their branches.
Here's the catch. The prostatic arteries are small, twisty, and notoriously inconsistent — they branch off in different places in different men, and a "textbook" origin is more of a polite suggestion than a rule. So the workhorse imaging here is cone-beam CT on the angiography table: a quick spinning acquisition that builds a 3D map confirming, "Yes, this vessel actually feeds prostate, not rectum." You map both sides, then embolize until you see flow in the prostatic branches slow to a near-stop (often described as a pruned-tree or stagnant-flow endpoint).
The one complication that haunts every case
If you remember nothing else procedural, remember this: the prostatic arteries share a crowded block with arteries to the bladder, rectum, and penis. Embolic beads don't read street signs. Send them down the wrong branch and you get non-target embolization — ischemia of tissue that very much wanted to keep its blood supply.
The danger isn't usually a dramatic catastrophe — it's a bead drifting into a small anastomosis you didn't fully appreciate. This is exactly why cone-beam CT and meticulous angiography aren't optional flourishes; they're the safety net. When in doubt, map it again before you embolize.
Most real-world complications are mild and self-limited and get grouped under post-PAE syndrome: pelvic discomfort, urinary urgency or burning, sometimes a little blood in the urine, semen, or stool as small bits of tissue and vessel react to being cut off. It typically settles over days. The headline upside, compared with surgery, is that PAE largely spares sexual function — it doesn't carry TURP's well-known risk of retrograde ejaculation.
A useful framing for patients: TURP is plumbing (open the channel mechanically), PAE is starvation (shrink the gland over time). Both can work; they fail and disappoint in different ways. Symptom relief from PAE is real but generally a bit more modest and gradual than a technically successful TURP.
Aftercare and the bottom line
Recovery is usually quick — most men go home the same day with oral pain control and anti-inflammatories, and they're warned to expect a few days of pelvic ache and irritated urination. Follow-up tracks symptoms (often with a standardized urinary symptom score) and sometimes imaging to confirm the gland actually shrank.
The single sentence to carry away: PAE shrinks an enlarged prostate by embolizing its blood supply through tiny, treacherous arteries — and almost the entire skill of the procedure is making sure those beads land in the prostate and nowhere else.